Phase III study of docetaxel in combination with gemcitabine versus docetaxel in combination with capecitabine in patients with locally advanced or metastatic breast cancer

Trial Profile

Phase III study of docetaxel in combination with gemcitabine versus docetaxel in combination with capecitabine in patients with locally advanced or metastatic breast cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 01 May 2014

At a glance

  • Drugs Capecitabine; Docetaxel; Gemcitabine
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2009 Results have been reported in the Journal of Clinical Oncology.
    • 27 Apr 2007 Status changed from in progress to recruiting.
    • 15 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top